← FDA Drug Approvals (Drugs@FDA)

AGGRENOX

NDA · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 1999-11-22

Drug application

FDA Application #

NDA020884

Application type

New Drug Application

Brand name

AGGRENOX

Generic name

Aspirin

Active ingredients

ASPIRIN; DIPYRIDAMOLE

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

BOEHRINGER INGELHEIM

First approval

1999-11-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown